Panitumumab Intravenous and Reclipsen
Determining the interaction of Panitumumab Intravenous and Reclipsen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
Generic Name: desogestrel / ethinyl estradiol
Brand name: Azurette, Cyclessa, Desogen, Isibloom, Kariva, Mircette, Reclipsen, Apri, Bekyree, Caziant, Ortho-Cept, Solia, Cesia, Cyred
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Panitumumab Intravenous-Recombinate
- Panitumumab Intravenous-Recombinate recombinant
- Panitumumab Intravenous-Recombivax
- Panitumumab Intravenous-Recombivax HB
- Panitumumab Intravenous-Recombivax HB Adult
- Panitumumab Intravenous-Recombivax HB Dialysis Formulation
- Reclipsen-Panixine
- Reclipsen-Panixine DisperDose
- Reclipsen-Panlor
- Reclipsen-Panlor Tablet
- Reclipsen-Panlor Tablets
- Reclipsen-Panlor-DC